Ahmad S, Johnson J L, Jensen R A
Department of Biology, State University of New York, Binghamton 13901.
J Mol Evol. 1987;25(2):159-67. doi: 10.1007/BF02101758.
Evolutionary events that generated the three regulatory isozymes of 3-deoxy-D-arabino-heptulosonate 7-phosphate (DAHP) synthase present in contemporary strains of Escherichia coli have been proposed recently [Ahmad et al. (1986) J Bacteriol 165:146-154]. The phylogenetic subdivision of gram-negative prokaryotes studied (Superfamily B) includes enteric bacteria, an Oceanospirillum cluster, pseudomonad Group I (e.g., Pseudomonas aeruginosa), pseudomonad Group V (e.g., Xanthomonas), and the Acinetobacter grouping. DAHP synthase-phe, a regulatory isozyme subject to allosteric control by L-phenylalanine, was the last member of the isozyme family to evolve. Thus, DAHP synthase-phe is absent throughout Superfamily B except within the enteric lineage. Bacteria that make up the enteric lineage (Escherichia, Klebsiella, Erwinia, Serratia, Proteus, Aeromonas, and Alteromonas) were examined in detail; DAHP synthase-phe was present in each of these organisms. Therefore, the isozyme originated between the separation of the enteric and Oceanospirillum lineages, prior to the divergence of Alteromonas putrefaciens (44% homology with E. coli by DNA:rRNA hybridization) from the rest of the enteric lineage. DAHP synthase-tyr and DAHP synthase-trp were uniformly present within the enteric lineage, although it was often necessary to derepress DAHP synthase-trp by physiological manipulation in order to demonstrate its presence.
最近有人提出了在当代大肠杆菌菌株中产生3-脱氧-D-阿拉伯庚酮糖酸-7-磷酸(DAHP)合酶三种调节同工酶的进化事件[Ahmad等人(1986年),《细菌学杂志》165:146 - 154]。所研究的革兰氏阴性原核生物的系统发育细分(超家族B)包括肠道细菌、海洋螺菌属簇、假单胞菌第一组(如铜绿假单胞菌)、假单胞菌第五组(如黄单胞菌)和不动杆菌属类群。DAHP合酶-苯丙氨酸是一种受L-苯丙氨酸变构控制的调节同工酶,是同工酶家族中最后进化的成员。因此,除了在肠道菌系中,超家族B的所有成员都没有DAHP合酶-苯丙氨酸。详细研究了构成肠道菌系的细菌(大肠杆菌、克雷伯氏菌、欧文氏菌、沙雷氏菌、变形杆菌、气单胞菌和交替单胞菌);这些生物体中的每一个都存在DAHP合酶-苯丙氨酸。因此,这种同工酶起源于肠道菌系和海洋螺菌属菌系分离之后,在腐败交替单胞菌(通过DNA:rRNA杂交与大肠杆菌有44%的同源性)与肠道菌系的其他成员分化之前。DAHP合酶-酪氨酸和DAHP合酶-色氨酸在肠道菌系中普遍存在,尽管通常需要通过生理操作来解除对DAHP合酶-色氨酸的抑制,以便证明它的存在。